The Motley Fool··Robert IzquierdoGeneDx Director's $13.8M Share Bet Signals Confidence Despite $63M Loss
GeneDx board member Keith Meister buys 351,273 shares for $13.8M amid stock decline and major quarterly loss, betting on turnaround.
WGSWGSWWstock declineprofitability concerns